I love helping my clients launch and grow their businesses.
About William
William represents both companies and investors in a range of industries. His practice focuses on venture capital financings, mergers and acquisitions, and corporate governance.
Prior to practicing law, William worked as a business manager at Capital One. He focused on rewards currency analytics, digital marketing and new product development.
William received his JD/MBA from the University of Virginia where he was president of the JD/MBA Society. He received his BS from the University of Virginia McIntire School of Commerce, with concentrations in finance and marketing.
Representative company-side and underwriter-side public offerings:
- Aclaris Therapeutics – $92.9 million follow-on offering
- Epizyme – $75 million follow-on offering
- Argenx SE – $86.5 million follow-on offering
- Autolus Therapeutics – $150 million IPO
- Helius Medical Technologies – $16 million follow-on offering
- Biohaven Pharmaceutical Holding – $193.6 million IPO
Education
University of Virginia School of Law
JD, 2016
University of Virginia Darden School of Business
MBA, 2016
University of Virginia McIntire School of Commerce
BS, 2008